中国现代中药2023，Vol.25Issue(10)：2045-2054,10.DOI:10.13313/j.issn.1673-4890.20230602003
2022年全国中药材及饮片质量分析概况
Quality Overview of Chinese Medicinal Materials and Decoction Pieces in 2022
张萍 1郭晓晗 1金红宇 1姚令文 1程显隆 1魏锋 1马双成1
作者信息
- 1. 中国食品药品检定研究院,北京 102629
- 折叠
摘要
Abstract
In early 2022,the State Council's General Office issued the 14th Five-Year Plan for Traditional Chinese Medicine Development,which outlines specific requirements to strengthen the safety regulation of Chinese medicine,enhance the capability to evaluate Chinese medicine quality,establish a comprehensive Chinese medicine quality safety supervision mechanism,and strengthen the management of the sources of Chinese medicine decoction pieces,aiming at promoting the high-quality development of the Chinese medicine industry.In 2022,under the leadership and organization of the National Medical Products Administration and provincial drug supervision and management departments,the nationwide results of inspections of Chinese medicinal materials and decoction pieces continued to be summarized.The data from inspections conducted in 31 provinces,autonomous regions,and municipalities were analyzed to assess the overall quality situation,the overall pass rate was 98%.Relevant regulatory strategies and recommendations were proposed to address quality and standard issues,thereby providing big data support to improve standards of Chinese medicinal materials and decoction pieces and enhance regulatory effectiveness and capabilities.关键词
中药材/饮片/质量/监管Key words
Chinese medicinal materials/decoction pieces/quality/supervision strategies分类
医药卫生引用本文复制引用
张萍,郭晓晗,金红宇,姚令文,程显隆,魏锋,马双成..2022年全国中药材及饮片质量分析概况[J].中国现代中药,2023,25(10):2045-2054,10.
